ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 25, Issue 10, Pages 1871-1888
Publisher
Oxford University Press (OUP)
Online
2014-09-19
DOI
10.1093/annonc/mdu385
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Open-label phase III randomized controlled trial comparing taxane-based chemotherapy (Tax) with lapatinib (L) or trastuzumab (T) as first-line therapy for women with HER2+ metastatic breast cancer: Interim analysis (IA) of NCIC CTG MA.31/GSK EGF 108919.
- (2017) Karen A. Gelmon et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary results from EMILIA, a phase III study of trastuzumab emtansine (T-DM1) versus capecitabine (X) and lapatinib (L) in HER2-positive locally advanced or metastatic breast cancer (MBC) previously treated with trastuzumab (T) and a taxane.
- (2017) Kimberly L. Blackwell et al. JOURNAL OF CLINICAL ONCOLOGY
- First international consensus guidelines for breast cancer in young women (BCY1)
- (2014) Ann H. Partridge et al. BREAST
- The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis
- (2014) Fausto Petrelli et al. BREAST CANCER RESEARCH AND TREATMENT
- 1LBA Everolimus plus exemestane for hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2–) advanced breast cancer (BC): overall survival results from BOLERO-2
- (2014) M. Piccart et al. EUROPEAN JOURNAL OF CANCER
- Can Patient Navigation Improve Receipt of Recommended Breast Cancer Care? Evidence From the National Patient Navigation Research Program
- (2014) Naomi Y. Ko et al. JOURNAL OF CLINICAL ONCOLOGY
- Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
- (2014) Camilla Zimmermann et al. LANCET
- Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial
- (2014) Stefan Aebi et al. LANCET ONCOLOGY
- Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment
- (2014) Jeremy M. Kilburn et al. RADIOTHERAPY AND ONCOLOGY
- 'IS IT MY LAST CHRISTMAS DINNER?' SURVIVAL OF CANCER PATIENTS HAVING PALLIATIVE CHEMOTHERAPY DURING CHRISTMAS PERIOD
- (2014) Rafael Silverman et al. BMJ Supportive & Palliative Care
- Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
- (2013) Denise A. Yardley et al. ADVANCES IN THERAPY
- International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)–MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer
- (2013) Nancy U. Lin et al. BREAST
- Supportive care after curative treatment for breast cancer (survivorship care): Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement
- (2013) Patricia A. Ganz et al. BREAST
- Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement
- (2013) Fatima Cardoso et al. BREAST
- Long-term follow-up of patients with metastatic breast cancer treated by trastuzumab: Impact of institutions
- (2013) Frederic Fiteni et al. BREAST
- What is the burden of axillary disease after neoadjuvant therapy in women with locally advanced breast cancer?
- (2013) C. Cox et al. Current Oncology
- An update on male breast cancer and future directions for research and treatment
- (2013) Berta Sousa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
- (2013) Sandra M Swain et al. LANCET ONCOLOGY
- Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial
- (2013) Stephen RD Johnston et al. LANCET ONCOLOGY
- Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial
- (2013) Aman U Buzdar et al. LANCET ONCOLOGY
- Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy
- (2013) Heath D Skinner et al. Radiation Oncology
- When to order a biopsy to characterise a metastatic relapse in breast cancer
- (2012) T. Foukakis et al. ANNALS OF ONCOLOGY
- 1st International consensus guidelines for advanced breast cancer (ABC 1)
- (2012) F. Cardoso et al. BREAST
- A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study
- (2012) E. Alba et al. BREAST CANCER RESEARCH AND TREATMENT
- Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer
- (2012) Joanne L. Blum et al. BREAST CANCER RESEARCH AND TREATMENT
- Radiosensitization induced by the anti-epidermal growth factor receptor monoclonal antibodies cetuximab and nimotuzumab in A431 cells
- (2012) Jorge Ernesto González et al. CANCER BIOLOGY & THERAPY
- The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
- (2012) Fatima Cardoso et al. EUROPEAN JOURNAL OF CANCER
- Can Locoregional Treatment of the Primary Tumor Improve Outcomes for Women With Stage IV Breast Cancer at Diagnosis?
- (2012) David H.A. Nguyen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Randomized Controlled Trial Comparing Primary Tumour Resection Plus Systemic Therapy With Systemic Therapy Alone in Metastatic Breast Cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017
- (2012) T. Shien et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2012) Javier Cortés et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
- (2012) Thomas Bachelot et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial
- (2012) Norikazu Masuda et al. LANCET ONCOLOGY
- Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
- (2012) Laura Biganzoli et al. LANCET ONCOLOGY
- Surgery of primary tumors in stage IV breast cancer: an updated meta-analysis of published studies with meta-regression
- (2012) Fausto Petrelli et al. MEDICAL ONCOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammatory Breast Cancer: What We Know and What We Need to Learn
- (2012) H. Yamauchi et al. ONCOLOGIST
- SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation
- (2012) Jetske Ruiterkamp et al. BMC Surgery
- Re-surgery and chest wall re-irradiation for recurrent breast cancer - a second curative approach
- (2011) Arndt-Christian Müller et al. BMC CANCER
- Breast cancer management in low resource countries (LRCs): Consensus statement from the Breast Health Global Initiative
- (2011) Nagi S. El Saghir et al. BREAST
- Evaluation of the evidence on staging imaging for detection of asymptomatic distant metastases in newly diagnosed breast cancer
- (2011) M.E. Brennan et al. BREAST
- Surgery of the primary tumor does not improve survival in stage IV breast cancer
- (2011) Laura Dominici et al. BREAST CANCER RESEARCH AND TREATMENT
- Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden
- (2011) Theodoros Foukakis et al. BREAST CANCER RESEARCH AND TREATMENT
- ACR Appropriateness Criteria® Locally Advanced Breast Cancer
- (2011) Shannon M. MacDonald et al. Breast Journal
- Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
- (2011) Eitan Amir et al. CANCER TREATMENT REVIEWS
- Surgery in metastatic breast cancer: Patients with a favorable profile seem to have the most benefit from surgery
- (2011) Z.M. Rashaan et al. EJSO
- The role of surgery in metastatic breast cancer
- (2011) Jetske Ruiterkamp et al. EUROPEAN JOURNAL OF CANCER
- RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2011) Adam M. Brufsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Capecitabine Versus Classical Cyclophosphamide, Methotrexate, and Fluorouracil As First-Line Chemotherapy for Advanced Breast Cancer
- (2011) Martin R. Stockler et al. JOURNAL OF CLINICAL ONCOLOGY
- RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
- (2011) Nicholas J. Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031
- (2011) Matthew J. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
- (2011) Javier Cortes et al. LANCET
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
- (2010) S. Dawood et al. ANNALS OF ONCOLOGY
- Cisplatin–gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients
- (2010) Nebu Koshy et al. BREAST
- Pattern of care in locally advanced breast cancer: Focus on local therapy
- (2010) Marcin Sinacki et al. BREAST
- Stage IV breast cancer in the era of targeted therapy
- (2010) Heather B. Neuman et al. CANCER
- Patient Navigation in Breast Cancer
- (2010) Stephanie Robinson-White et al. CANCER NURSING
- 453 Trends in survival in metastatic breast cancer
- (2010) M. Sundquist et al. EJC SUPPLEMENTS
- Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
- (2010) Angelo Di Leo et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study
- (2010) Michael Andersson et al. JOURNAL OF CLINICAL ONCOLOGY
- International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
- (2010) O. Pagani et al. JNCI-Journal of the National Cancer Institute
- Sensitization to Radiation and Alkylating Agents by Inhibitors of Poly(ADP-ribose) Polymerase Is Enhanced in Cells Deficient in DNA Double-Strand Break Repair
- (2010) D. A. Loser et al. MOLECULAR CANCER THERAPEUTICS
- The Missing Voice of Patients in Drug-Safety Reporting
- (2010) Ethan Basch NEW ENGLAND JOURNAL OF MEDICINE
- Durable palliation of breast cancer chest wall recurrence with radiation therapy, hyperthermia, and chemotherapy
- (2010) Timothy M. Zagar et al. RADIOTHERAPY AND ONCOLOGY
- Metastatic breast cancer patients: The forgotten heroes!
- (2009) Fatima Cardoso BREAST
- Loco-regional treatment in metastatic breast cancer patients: Is there a survival benefit?
- (2009) Bevan H. Ly et al. BREAST CANCER RESEARCH AND TREATMENT
- Radiosensitization of Chemotherapy-Refractory, Locally Advanced or Locally Recurrent Breast Cancer With Trastuzumab: A Phase II Trial
- (2009) Janet K. Horton et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy
- (2009) Tomasz Byrski et al. JOURNAL OF CLINICAL ONCOLOGY
- International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
- (2009) Fatima Cardoso et al. JNCI-Journal of the National Cancer Institute
- Selecting High Priority Quality Measures For Breast Cancer Quality Improvement
- (2009) Michael J. Hassett et al. MEDICAL CARE
- Patient Navigation Through the Cancer Care Continuum: An Overview
- (2009) Janice Hopkins et al. Journal of Oncology Practice
- Prognostic factors in 1038 women with metastatic breast cancer
- (2008) R. Largillier et al. ANNALS OF ONCOLOGY
- Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
- (2008) T. Byrski et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast Cancer in Men-Should Aromatase Inhibitors Become First-Line Hormonal Treatment?
- (2008) Ina C. Nordman et al. Breast Journal
- National Cancer Institute Patient Navigation Research Program
- (2008) Karen M. Freund et al. CANCER
- Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer
- (2008) Martine J. Piccart-Gebhart et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group
- (2008) Robert J. Paridaens et al. JOURNAL OF CLINICAL ONCOLOGY
- Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT
- (2008) Stephen Chia et al. JOURNAL OF CLINICAL ONCOLOGY
- Locally Advanced and Inflammatory Breast Cancer
- (2008) Stephen Chia et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started